Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | ||
---|---|---|---|---|---|---|---|---|
Total Revenue | ||||||||
Cost of Revenue | ||||||||
Gross Profit | ||||||||
Gross Profit Margin (%) | ||||||||
R&D Expense | ||||||||
SG&A Expense | ||||||||
Total Operating Expenses | ||||||||
Operating Income or Loss | ||||||||
Operating Margin (%) | ||||||||
Interest Expense | ||||||||
Total Other Income/Expenses | ||||||||
Income Before Tax | ||||||||
Income Tax Expense | ||||||||
Income from Continuing Ops. | ||||||||
Net Income | ||||||||
Net Profit Margin (%) | ||||||||
Net Income Available to Common Shareholders | ||||||||
Basic EPS | ||||||||
Diluted EPS | ||||||||
Basic Average Shares | ||||||||
Diluted Average Shares |
Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | Dec 2020 | Sep 2020 | Jun 2020 | Mar 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Revenue | |||||||||||||||||
Cost of Revenue | |||||||||||||||||
Gross Profit | |||||||||||||||||
Gross Profit Margin (%) | |||||||||||||||||
R&D Expense | |||||||||||||||||
SG&A Expense | |||||||||||||||||
Total Operating Expenses | |||||||||||||||||
Operating Income or Loss | |||||||||||||||||
Operating Margin (%) | |||||||||||||||||
Interest Expense | |||||||||||||||||
Total Other Income/Expenses | |||||||||||||||||
Income Before Tax | |||||||||||||||||
Income Tax Expense | |||||||||||||||||
Income from Continuing Ops. | |||||||||||||||||
Net Income | |||||||||||||||||
Net Profit Margin (%) | |||||||||||||||||
Net Income Available to Common Shareholders | |||||||||||||||||
Basic EPS | |||||||||||||||||
Diluted EPS | |||||||||||||||||
Basic Average Shares | |||||||||||||||||
Diluted Average Shares |
Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | ||
---|---|---|---|---|---|---|---|---|
Current Assets | ||||||||
Cash & Cash Equivalents | ||||||||
Marketable Securities | ||||||||
Receivables | ||||||||
Inventories | ||||||||
Other Current Assets | ||||||||
Total Current Assets | ||||||||
Non-Current Assets | ||||||||
Marketable Securities | ||||||||
PPE Net | ||||||||
Intangibles inc. Goodwill | ||||||||
Other Non-Current Assets | ||||||||
Total Non-Current Assets | ||||||||
Total Assets | ||||||||
Current Liabilities | ||||||||
Accounts Payable | ||||||||
Deferred Revenues | ||||||||
Debt, Current | ||||||||
Accrued Liabilities | ||||||||
Other Current Liabilities | ||||||||
Total Current Liabilities | ||||||||
Non-Current Liabilities | ||||||||
Deferred Revenues | ||||||||
Debt, Non-Current | ||||||||
Other Non-Current Liabilities | ||||||||
Total Non-Current Liabilities | ||||||||
Total Liabilities | ||||||||
Shareholders' Equity | ||||||||
Common Stock | ||||||||
Additional Paid-In Capital | ||||||||
Retained Earnings | ||||||||
Other Shareholders' Equity | ||||||||
Total Shareholders' Equity | ||||||||
Total Liabilities & Shareholders' Equity |
Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | Dec 2020 | Sep 2020 | Jun 2020 | Mar 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Current Assets | |||||||||||||||||
Cash & Cash Equivalents | |||||||||||||||||
Marketable Securities | |||||||||||||||||
Receivables | |||||||||||||||||
Inventories | |||||||||||||||||
Other Current Assets | |||||||||||||||||
Total Current Assets | |||||||||||||||||
Non-Current Assets | |||||||||||||||||
Marketable Securities | |||||||||||||||||
PPE Net | |||||||||||||||||
Intangibles inc. Goodwill | |||||||||||||||||
Other Non-Current Assets | |||||||||||||||||
Total Non-Current Assets | |||||||||||||||||
Total Assets | |||||||||||||||||
Current Liabilities | |||||||||||||||||
Accounts Payable | |||||||||||||||||
Deferred Revenues | |||||||||||||||||
Debt, Current | |||||||||||||||||
Accrued Liabilities | |||||||||||||||||
Other Current Liabilities | |||||||||||||||||
Total Current Liabilities | |||||||||||||||||
Non-Current Liabilities | |||||||||||||||||
Deferred Revenues | |||||||||||||||||
Debt, Non-Current | |||||||||||||||||
Other Non-Current Liabilities | |||||||||||||||||
Total Non-Current Liabilities | |||||||||||||||||
Total Liabilities | |||||||||||||||||
Shareholders' Equity | |||||||||||||||||
Common Stock | |||||||||||||||||
Additional Paid-In Capital | |||||||||||||||||
Retained Earnings | |||||||||||||||||
Other Shareholders' Equity | |||||||||||||||||
Total Shareholders' Equity | |||||||||||||||||
Total Liabilities & Shareholders' Equity |
Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | ||
---|---|---|---|---|---|---|---|---|
Cash Flows from Operating Activities | ||||||||
Net Income | ||||||||
Depreciation & Amortization | ||||||||
Deferred Income Taxes | ||||||||
Stock Based Compensation | ||||||||
Accounts Receivable | ||||||||
Inventory | ||||||||
Accounts Payable | ||||||||
Deferred Revenue | ||||||||
Other Non-Cash | ||||||||
Operating Cash Flow | ||||||||
Cash Flows from Investing Activities | ||||||||
PPE Investments | ||||||||
Net Acquisitions | ||||||||
Purchase of Investments | ||||||||
Sale of Investments | ||||||||
Other Investing Activity | ||||||||
Investing Cash Flow | ||||||||
Cash Flows from Financing Activities | ||||||||
Debt Issued | ||||||||
Proceeds from Debt Repayment | ||||||||
Debt Repayment | ||||||||
Proceeds from Sale of Equity | ||||||||
Equity Repurchased | ||||||||
Dividend Paid | ||||||||
Other Financing Activity | ||||||||
Financing Cash Flow | ||||||||
Cash Position | ||||||||
Beginning Cash Position | ||||||||
End Cash Position | ||||||||
Change in Cash | ||||||||
Free Cash Flow | ||||||||
Operating Cash Flow | ||||||||
Capital Expenditure | ||||||||
Free Cash Flow |
Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | Dec 2020 | Sep 2020 | Jun 2020 | Mar 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash Flows from Operating Activities | |||||||||||||||||
Net Income | |||||||||||||||||
Depreciation & Amortization | |||||||||||||||||
Deferred Income Taxes | |||||||||||||||||
Stock Based Compensation | |||||||||||||||||
Accounts Receivable | |||||||||||||||||
Inventory | |||||||||||||||||
Accounts Payable | |||||||||||||||||
Deferred Revenue | |||||||||||||||||
Other Non-Cash | |||||||||||||||||
Operating Cash Flow | |||||||||||||||||
Cash Flows from Investing Activities | |||||||||||||||||
PPE Investments | |||||||||||||||||
Net Acquisitions | |||||||||||||||||
Purchase of Investments | |||||||||||||||||
Sale of Investments | |||||||||||||||||
Other Investing Activity | |||||||||||||||||
Investing Cash Flow | |||||||||||||||||
Cash Flows from Financing Activities | |||||||||||||||||
Debt Issued | |||||||||||||||||
Proceeds from Debt Repayment | |||||||||||||||||
Debt Repayment | |||||||||||||||||
Proceeds from Sale of Equity | |||||||||||||||||
Equity Repurchased | |||||||||||||||||
Dividend Paid | |||||||||||||||||
Other Financing Activity | |||||||||||||||||
Financing Cash Flow | |||||||||||||||||
Cash Position | |||||||||||||||||
Beginning Cash Position | |||||||||||||||||
End Cash Position | |||||||||||||||||
Change in Cash | |||||||||||||||||
Free Cash Flow | |||||||||||||||||
Operating Cash Flow | |||||||||||||||||
Capital Expenditure | |||||||||||||||||
Free Cash Flow |